Written by the Nuvirox Research Team
Key Points
- A small randomized, placebo-controlled trial found ashwagandha extract reduced knee pain and improved WOMAC scores over 12 weeks in a dose-dependent way.
- The trial had only 60 participants at a single site, and larger network meta-analyses rank it as a modest performer compared to some other botanical extracts.
- Ashwagandha can affect thyroid hormones and isn't recommended in pregnancy, which matters for anyone considering it for joint pain.
A note on when to see a clinician: Ashwagandha can affect thyroid hormone levels and isn't recommended during pregnancy or while breastfeeding. If you have a thyroid condition, an autoimmune disease, or take sedatives, immunosuppressants, or thyroid medication, check with a doctor before adding it.
Short answer: there's a real signal from one well-designed but small trial, not yet a large or independently replicated evidence base. Ashwagandha (Withania somnifera) has a long history in Ayurvedic medicine for joint complaints, and a randomized, double-blind, placebo-controlled trial found it reduced knee pain and improved function over 12 weeks in a dose-dependent way. That's a genuinely promising result — but it comes from a single 60-person trial at one research site, which is a much thinner evidence base than the willow bark or massage research covered elsewhere in this batch.
What is ashwagandha supposed to do for an arthritic joint?
Ashwagandha root and leaf extracts have shown anti-inflammatory, analgesic, and chondroprotective (cartilage-protective) effects in laboratory and animal research, including inhibition of the cyclo-oxygenase (COX) pathway involved in inflammation and pain signaling — a mechanism broadly similar in concept, though not in strength, to how NSAIDs work.
What is ashwagandha supposed to do for an arthritic joint?
Ashwagandha root and leaf extracts have shown anti-inflammatory, analgesic, and chondroprotective (cartilage-protective) effects in laboratory and animal research, including inhibition of the cyclo-oxygenase (COX) pathway involved in inflammation and pain signaling — a mechanism broadly similar in concept, though not in strength, to how NSAIDs work. Ashwagandha is classified in Ayurvedic medicine as a rasayana, or rejuvenating tonic, and has traditionally been used for a wide range of inflammatory conditions, joint pain among them, for centuries before it was tested in a modern randomized trial.
What the human trial actually found
The key clinical evidence is a randomized, double-blind, placebo-controlled trial (Ramakanth et al., J Ayurveda Integr Med, 2016) conducted at Nizam's Institute of Medical Sciences in India. Sixty patients with knee pain were randomized to a standardized aqueous extract of Withania somnifera roots and leaves at either 500 mg/day, 250 mg/day, or placebo for 12 weeks, with all participants stopping other pain medication before the study started. The primary outcome was percent change in modified WOMAC score.
Study snapshot: Ashwagandha for knee joint pain (Ramakanth et al., J Ayurveda Integr Med, 2016)
| Design | RCT, double-blind, placebo-controlled, dose-ranging |
| n | 60 patients with knee pain |
| Duration | 12 weeks |
| Doses tested | 500 mg/day, 250 mg/day, placebo |
| Finding | Dose-dependent improvement in modified WOMAC, pain (VAS), stiffness, and disability scores; onset as early as 4 weeks in the 250 mg group |
| Safety | Well tolerated, good safety profile reported |
The honest counterweight
This is a real, well-designed trial, but it's still just one trial, at one site, with 60 total participants split across three arms — a much smaller and less independently replicated evidence base than exists for, say, willow bark or the exercise-based approaches covered elsewhere in this batch. A network meta-analysis pooling 36 randomized trials (3,285 participants) of botanical extracts for knee osteoarthritis found ashwagandha extract was significantly more effective than placebo specifically for reducing stiffness scores, but ranked behind another botanical (cucumber extract) as the top-performing option for pain and function in that pooled analysis — a useful reminder that a positive individual trial doesn't automatically mean an ingredient is the strongest option in its category.
What ashwagandha won't do
Based on current evidence, it hasn't been shown to rebuild cartilage or reverse structural joint damage, and given the thin trial base, it shouldn't be treated as a settled, well-established option the way something with a larger body of research would be. It's also worth being clear-eyed that most supplement marketing around ashwagandha and joints is leaning on this single trial.
Who should be cautious with ashwagandha
Ashwagandha has documented effects on thyroid hormone levels and isn't recommended during pregnancy or while breastfeeding. It may also interact with sedatives, immunosuppressants, and thyroid medications, and its safety alongside other joint-support supplements like zinc hasn't been specifically studied. If you have a thyroid condition, autoimmune disease, or take any of those medication classes, check with a doctor before starting it. It's also worth knowing that ashwagandha's other studied uses — stress, sleep, and hormonal support — come from entirely separate research than the knee-pain trial discussed here, so a supplement marketed broadly for "stress and joints" may be leaning on different evidence for each claim.
How ashwagandha compares to other options in this batch
If you're weighing ashwagandha against other joint-support ingredients covered here, it's worth being honest about relative evidence weight: willow bark has two separate randomized trials including a large three-arm comparison; ashwagandha has one. That doesn't mean ashwagandha doesn't work — it means the case for it rests on a thinner foundation, which is worth factoring into how much confidence you place in the result. Our piece on white willow bark lays out that comparison in more depth.
How long before ashwagandha might help joint pain, based on the trial?
The 2016 trial found onset of benefit as early as 4 weeks in the lower-dose (250 mg) group, with the full 12-week course used to measure the primary outcome.
Is a higher ashwagandha dose better for joint pain?
The trial found a dose-dependent response, with the 500 mg/day group showing greater improvement than the 250 mg/day group, though this comes from one trial and hasn't been independently confirmed.
Does ashwagandha help rheumatoid arthritis, not just osteoarthritis-type knee pain?
Separate, smaller pilot research has looked at ashwagandha powder combinations for rheumatoid arthritis with some positive signals, but this is an even thinner evidence base than the knee pain trial and shouldn't be treated as established.
Can I take ashwagandha alongside my current arthritis medication?
The 2016 trial had participants stop other pain medications before starting, so it doesn't tell us how ashwagandha interacts with ongoing NSAID or DMARD therapy; check with a doctor before combining.
Is ashwagandha the same as other "adaptogen" herbs marketed for joint pain?
No — adaptogen is a broad marketing category covering many different herbs with different evidence bases; the knee-pain trial discussed here applies specifically to a standardized Withania somnifera root-and-leaf extract, not to adaptogens generally.
From Nuvirox
Why we formulated Joint+ Restore
Joint+ Restore is our joint-support formula, built around ingredients studied for cartilage, comfort, and mobility support as part of a broader approach to joint health. Our formula is currently being updated, so we're not listing specific ingredient amounts here — but the goal stays the same: a joint-support supplement worth taking consistently. It's backed by our 60-day money-back guarantee, long enough to actually judge whether it's doing anything for you.
Learn more about Joint+ Restore →The bottom line: One well-designed randomized trial found ashwagandha extract eased knee pain and stiffness in a dose-dependent way over 12 weeks — a genuinely encouraging result. But it's a single, small, single-site trial, and a broader network meta-analysis suggests it isn't necessarily the standout performer among botanical options. Worth considering, not yet worth treating as settled science.
References
- Ramakanth GSH, Uday Kumar C, Kishan PV, Usharani P. A randomized, double blind placebo controlled study of efficacy and tolerability of Withaina somnifera extracts in knee joint pain. J Ayurveda Integr Med. 2016;7(3):151-157. PMID: 27647541.
- Efficacy of botanical extracts for knee osteoarthritis: a network meta-analysis of randomized controlled trials. PMC12537895.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.